World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
26016
World Ranking
13716
National Ranking
6966

Overview

David M. Purdie is affiliated with Global Blood Therapeutics in the United States. Their research primarily spans the field of Medicine, with specific focus on Genetics and Hematology as key subfields.

The scientist's work centers on Hemoglobinopathies and Related Disorders, along with related topics such as Iron Metabolism and Disorders. They have also contributed to studies concerning Blood donation and transfusion practices, as well as Historical Economic and Social Studies and Historical Studies on Reproduction, Gender, Health, and Societal Changes.

David M. Purdie's recent publications include the following papers:

  • "PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY," 2023, published in HemaSphere
  • "Qualitative Interview Study to Characterize the Treatment Experiences of Participants with Sickle Cell Disease and Assess Perceptions of Red Blood Cell Transfusions," 2024, published in Blood
  • "Study of Real-World Treatment Patterns in Patients with Sickle Cell Disease Using US Medicaid Claims Data," 2024, published in Blood
  • "A Validation Study of Red Blood Cell Transfusions in Patients with Sickle Cell Disease Using Optum Electronic Health Records and Administrative Claims Data," 2024, published in Blood
  • "Real-World Patient-Reported Sickle Cell Disease Burden in the United States," 2024, published in Blood

The majority of their publications have appeared in the journal Blood, where they have contributed five articles. Another publication is featured in HemaSphere, and one is in Value in Health.

Frequent collaborators in David M. Purdie's research include:

  • Carmine Colavecchia
  • Emily Riehm Meier
  • Christine L. Baker
  • Yun Gu
  • Giovanna Tedesco Barcelos

Best Publications

  • Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

    Luke F. Hourigan;Graeme A. Macdonald;David Purdie;Vicki H. Whitehall

  • Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

    Axel Grothey;Mary M. Sugrue;David M. Purdie;Wei Dong

  • Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

    Kim R Bridle;David M Frazer;Sarah J Wilkins;Jeanette L Dixon

  • Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

    I J Hickman;J R Jonsson;J B Prins;S Ash

  • Host genetic factors influence disease progression in chronic hepatitis C

    Elizabeth E. Powell;Catherine J. Edwards-Smith;John L. Hay;Andrew D. Clouston

  • Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

    Catherine J. Edwards‐Smith;Julie R. Jonsson;David M. Purdie;Amolak Bansal

  • Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

    Roberta B. Ness;Daniel W. Cramer;Marc T. Goodman;Susanne Krûger Kjaer

  • Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma

    David C. Whiteman;Peter Watt;David M. Purdie;Maria Celia Hughes

  • Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction

    Michelle M Richardson;Julie R Jonsson;Elizabeth E Powell;Elizabeth M Brunt

  • Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study

    Mark Kozloff;Marianne Ulcickas Yood;Jordan Berlin;Patrick J. Flynn

  • Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

    I J Hickman;A D Clouston;G A Macdonald;D M Purdie

  • Quality of Reporting of Observational Longitudinal Research

    Leigh Tooth;Robert Ware;Chris Bain;David M. Purdie

  • Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis

    Julie R. Jonsson;Andrew D. Clouston;Yuichi Ando;Livia I. Kelemen

  • Non‐response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS‐3) in patients with chronic hepatitis C, viral genotype 1

    Meagan J Walsh;Julie R Jonsson;Michelle M Richardson;Geraldine Lipka

  • Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.

    Linda M. Fletcher;Jeannette L. Dixon;David M. Purdie;Lawrie W. Powell

  • Reproductive and other factors and risk of epithelial ovarian cancer: An australian case-control study

    David Purdie;Adèle Green;Christopher Bain;Victor Siskind

  • Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.

    Kevin Spring;Farida Ahangari;Shaun P. Scott;Paul Waring

  • Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes

    Michael S. Roberts;Julie A. Stokes;Michelle A. King;Teresa A. Lynne

  • Epidemiology of endometrial cancer.

    David M. Purdie;Adèle C. Green

  • Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

    K.R. Bridle;D.M. Frazer;S.J. Wilkins;J.L. Dixon

Frequent Co-Authors

Adèle C. Green
Adèle C. Green QIMR Berghofer Medical Research Institute
Chris Bain
Chris Bain Monash University
Penelope M. Webb
Penelope M. Webb QIMR Berghofer Medical Research Institute
Andrew D. Clouston
Andrew D. Clouston University of Queensland
David C. Whiteman
David C. Whiteman QIMR Berghofer Medical Research Institute
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Darrell H. G. Crawford
Darrell H. G. Crawford University of Queensland
Brian H. Kay
Brian H. Kay QIMR Berghofer Medical Research Institute
Michael P. Dunne
Michael P. Dunne Queensland University of Technology
Nicholas Lennox
Nicholas Lennox University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing a medical or healthcare career in the USA, there are various online degree programs that can streamline your path into advanced practice roles. Many professionals seek out accelerated msn to dnp programs to move quickly from a Master of Science in Nursing (MSN) to a Doctor of Nursing Practice (DNP), often while continuing to work.

Financial considerations are also important. Some learners prioritize enrolling in cheapest dnp programs that balance quality with affordability, helping to reduce long-term debt.

Those looking for entry-level roles may consider fast track medical programs such as online Licensed Practical Nurse (LPN) pathways, which can expedite access to the workforce.

If you have a keen interest in mental health, pursuing psych np programs can equip you for specialized roles as a Psychiatric Nurse Practitioner, meeting the growing demand for mental health professionals.

Best Scientists Citing David M. Purdie

Trending Scientists

Recently Published Articles